Support fundamental research & trials to extend active lifespan up to 100 years

Support fundamental research & trials to extend active lifespan up to 100 years

0 have signed. Let’s get to 25!
At 25 signatures, this petition is more likely to be featured in recommendations!
Oleg Teterin started this petition to Justin Trudeau

Longevity Dividend Canada: Petition

To Justin Trudeau      

Support fundamental research & trials to extend active lifespan up to 100 years

Every day 150,000 people die in the world. 3 in every 4 deaths are categorised as being from age-related diseases.

The main causes of death include Heart Attack, Stroke, Lung and other Respiratory diseases, Cancer, Alzheimer's disease, and other types of neurodegenerative disorders.

Today’s global average life expectancy is now 72 years. This is an astounding increase change in the last two centuries as in 1800 the global life expectancy was 29. It is especially impressive as the global average today is higher than any country back in1950 when life expectancy was just 46. 

While clearly this increase in life expectancy is to be celebrated, the period of time during which people are critically ill has also extended. 

As deaths from infectious diseases and childhood mortality become much less frequent coupled with a decline in impact from heart attacks among those in middle-age, there are now more and more long term sufferers of diseases like cancers and neurodegenerative diseases. 

These diseases can lead to many years of suffering and the need for the state to spend vast sums of money in care facilities and services.

The current paradigm of healthcare is centred on treating these diseases when they present clinically. In recent years, however, progress in understanding of human biology has shown the potential benefits of moving upstream from these diseases and looking to intervene in the deterioration that precedes the disease. We normally refer to this deterioration, holistically, as “Aging”.

This re-examination leads to treating degenerative diseases in a preventative manner as well as curative. In what is becoming the most exciting area of human pursuit and quite possibly, even the biggest industry of all time the Longevity Era has begun.

It is important to emphasize that we are talking about healthy longevity, which is sometimes referred to as “Healthspan”. This indicates working towards better health as people advance in years or a longer period of life in good health. Any accompanying maximum lifespan increases are as yet theoretical. 

The social and financial benefits of an increase in healthspan are now well elucidated. Many refer to this as the “Longevity Dividend”.

The Longevity Dividend indicates the savings in costs of caring for people over an extended period of ill health and also the potential contributions of older individuals to a productive society.

There are also individual, family and social benefits to a deeper and longer integration of the wisdom accumulated over time to each community.

In Canada life expectancy now sits at 82.66 years, a significant distance behind many other countries’ average life expectancy including Monaco’s 89.5 years and beyond what is possible in the medium and long-term. 

There is currently a government R&D allocation dedicated to age related diseases, but it’s not enough.

This is a misallocation of resources that is based on a very outdated approach that is really ‘Sick-Care’ rather than ‘Health-Care’ and does not make the most of current scientific areas of interest, research and development

The business, science and societal opportunities available with a dedicated portion of the government’s annual budget to interdisciplinary research in anti-aging are immense.

Benefits that will alleviate suffering, reinforce healthcare and bring about the Longevity Dividend and all of its benefits.

A public and private moonshot style embrace of this industry of the 21st century could allow for dedicated educational, commercial and societal collaborations in research, clinical trials, age-tech and make Canada a leader in the field.

To facilitate this goal, this petition requests the Canadian Government to grant from budget 2022 onwards 5% of its expenditure to the field of Anti-Aging research under the banner of ‘Longevity Dividend Canada’.

These funds will be used for basic research on aging, anti-aging therapies, conducting clinical trials of new developments, financing modern technologies using artificial intelligence and big data. The aim would be to join up existing educational and commercial institutions associated with the state as well as private partners and, indeed, international partnerships to best move the field forward


By signing this petition, each of us are able to make a personal contribution to our own longevity and the longevity of our loved ones, and in the next 10 years, benefit from new developments and have a chance to live a high-quality, healthy and active life for as long as possible.

This petition will be submitted in each of the 252 countries of the world in more than 50 languages. It has already been submitted in:













East Timor:

Cabo Verde:

Guinea Bissau:


Sao Tome and Principe:

Equatorial Guinea:














Costa Rica:



Please share these links with your friends in those countries.

Follow the petition news in, probably, the biggest open channel on longevity in Telegram:


Oleg Teterin - Biotechnologist. Longevity InTime Founder. Co-producer: Awards winning “Chef”, directed by Jon Favreau (Lion King, Iron Man), starring Robert Downey Jr., Scarlett Johansson, Dustin Hoffman, Sofia Vergara, Jon Leguizamo. Moscow, Russia.

José Luis Cordeiro Mateo -  engineer (MIT), economist, futurist, and transhumanist, who has worked on different areas including economic development, international relations, Latin America, the European Union, monetary policy, comparison of constitutions, energy trends, cryonics, and longevity. Books he has authored include The Great Taboo, Constitutions Around the World: A Comparative View from Latin America, and (in Spanish) El Desafio Latinoamericano ("The Latin American challenge") and La Muerte de la Muerte ("The death of death"). Madrid, Spain.

Martin O Dea - Business Strategist and author. Active in the longevity field for over a decade. CEO of Longevity Accelerator. Dublin, Ireland.

Oliver Zolman - MD. Evidence-Based-Longevity expert, founder of 20one Clinics where ageing is measured in clients in all 78 organs, using MRI, ultrasound, devices and biofluids, and evidence-based Longevity 'Level 1 2 3 therapies' are used to reverse ageing in all organs. Cambridge, UK.

Ilia Stambler - PhD. Longevity expert and activist. Chief Science Officer of Vetek (Seniority) Association – the Movement for Longevity and Quality of Life, Israel. Board member of the International Longevity Alliance (ILA). Tel Aviv, Israel

Vyacheslav Krutko - Doctor of Technical Sciences, Candidate of Biological Sciences, Professor of SPSMU Sechenova, Head of the Laboratory of System Analysis and Information Technologies in Medicine and Ecology of the ISA RAS, Head of the project "System Technologies of Anti-aging Medicine”, Chairman of the Commission "Applied Gerontology" of the Scientific Council for Gerontology and Geriatrics. Moscow, Russia

Yusipova Yulia - PhD, MD, rector International Institute of Traditional Medicine, CEO International Institute of Integrative & Anti-aging Medicine (EU), Co-founder European University of Longevity. Moscow, Russia.

Dr. Reagan Edith Lorraine L - MBA, EdM, MALS, MLS, PhD Part-time professor of business, marketing and health business, and tutor of social sciences, and business, languages, and hard sciences. France.

Vinicius Esteves Teixeira - Holds bachelor's, master's, and Ph.D. in Theoretical and Computational Chemistry with experience in teaching and scientific research. Currently interested in longevity research development and in the implementation of public policies for the benefit of health for the general population. Porto Alegre, Brasil.

Mateus Potumati Mariano - CEO e Diretor de Conteúdo do Projeto VIVEAGORA, jornalista, tradutor, consultor de marcas e conteúdo com 20 anos de experiência, bacharel em Direito e Ciências Sociais, com especialização em design thinking pelo MIT. São Paulo, Brasil.

Sergio Martínez de Lahidalga Tarrero – BSc en física por la Universidad de Miami. Productor, realizador y editor audiovisual. Presidente de Alianza Futurista. Miembro de la Junta Directiva de Lifeboat Foundation.

Nina Skorytchenko, MSc, MA, BSc, NT, is a founder and CEO of Avenna and Wellcode Life. She is working in close collaboration with leading scientists and health care professionals in the field of precision health & wellness for inflammatory diseases. At her company Avenna, she leads translation of technology called Glyhealth, an in vitro diagnostic platform for Inflammatory Diseases. Their products include, glycomic biomarkers for early detection and treatment personalisation for conditions such as Inflammatory bowel disease and Covid-19.  Oxford, UK

Eliseo San Juan Poblete, Industrial Civil Engineer, Bachelor of Science, with experience in eco-sustainable projects, Founder of the Chrono Corrector Chile project, to teach non-scientists about life extension and longevity. Valparaiso, Chile

Wolfgang Möcklin, physician with experience in clinical-oncological stem cell research, research in the field of stem cell expansion, independent in the IT field, focus on antiaging. Freiburg im Breisgau, Germany.

David Blokh obtained his Ph. D. degree in Operations Research from the Ben-Gurion University of the Negev, Israel  in 1998. His research interests include combinatorial optimization, models and methods of generalized decision networks, information-theory analysis and pattern recognition, applying advanced data mining techniques in biomedicine and economics. He brings 35 years of experience in processing random data.

David Blokh has published over 40 scientific articles. His papers have appeared in Discrete Applied Mathematics, Information Systems and Operational Research, Computer Methods and Programs in Biomedicine, Cancer Detection and Prevention, Methods of Information in Medicine, Progress in Neurobiology, Mechanisms of Ageing and Development, Genomics & Informatics, Applied Medical Informatics.

Mitra Shokrollahi, Biomedical researcher and PhD student in Laboratory Medicine & Pathobiology at the University of Toronto, Canada

Bulat Gaifullin, PhD, Psychogerontologist, System Analyst in Longevity Medicine, Secretary of the Gerontology Section of the Moscow Society of Naturalists of Moscow State University, Member of the Board of the Moscow Branch of the Gerontological Society of the Russian Academy of Sciences, Member of the Canadian Longevity Association. Canada

0 have signed. Let’s get to 25!
At 25 signatures, this petition is more likely to be featured in recommendations!